Fahmawi Yazan, Campos Yesica, Khushman Moh'd, Alkharabsheh Omar, Manne Ashish, Zubair Haseeb, Haleema Saadia, Polski Jacek, Bessette Sabrina
Department of Internal Medicine, University of South Alabama, Mobile, AL, USA.
Department of Hematology-Oncology, Mitchell Cancer Institute, University of South Alabama, Mobile, AL, USA.
Clin Pharmacol. 2019 Aug 27;11:127-131. doi: 10.2147/CPAA.S207258. eCollection 2019.
Pseudo-thrombotic microangiopathy (pseudo-TMA) is a recognized, yet uncommon, clinical presentation of vitamin B12 deficiency. Patients with pseudo-TMA present with microangiopathic hemolytic anemia (MAHA), thrombocytopenia and schistocytes. They are often misdiagnosed as thrombotic thrombocytopenia purpura (TTP) and receive unnecessary therapy. Here, we report a case of a 60-year-old male who presented with thrombocytopenia and normocytic normochromic anemia. Anemia work-up was remarkable for severe B12 deficiency (<60 pg/mL) and a positive non-immune hemolysis panel. Peripheral smear was reviewed and showed anisocytes, poikilocytes, schistocytes and hypersegmented neutrophils. Vitamin B12 replacement (1000 mcg IM daily) was started, ADAMTS13 activity was sent and daily plasmapheresis was initiated. Over the next 3 days, the patient's hemoglobin and platelets were stable and the hemolysis panel showed gradual improvement. On day 4, ADAMTS13 activity results came back normal at 61%. Accordingly, plasmapheresis was discontinued, parenteral B12 replacement was continued and that resulted in gradual improvement and eventually cessation of hemolysis and normalization of hemoglobin and platelets. In this patient, parietal cell autoantibodies were positive and so the diagnosis of pernicious anemia was made. Patients with severe vitamin B12 deficiency may present with features mimicking TTP such as MAHA, thrombocytopenia and schistocytosis. An early and accurate diagnosis of pseudo-TMA has a critical clinical impact with respect to administering the correct treatment with vitamin B12 replacement and avoiding, or shortening the duration of, unnecessary therapy with plasmapheresis.
假性血栓性微血管病(pseudo-TMA)是维生素B12缺乏症一种已被认识但并不常见的临床表现。患有假性血栓性微血管病的患者表现为微血管病性溶血性贫血(MAHA)、血小板减少和裂红细胞。他们常被误诊为血栓性血小板减少性紫癜(TTP)并接受不必要的治疗。在此,我们报告一例60岁男性患者,其表现为血小板减少和正细胞正色素性贫血。贫血检查显示严重的B12缺乏(<60 pg/mL)且非免疫性溶血检查结果呈阳性。复查外周血涂片显示异形红细胞、异形红细胞、裂红细胞和多分叶核中性粒细胞。开始维生素B12替代治疗(每日1000 mcg,肌内注射),送检ADAMTS13活性并开始每日进行血浆置换。在接下来的3天里,患者的血红蛋白和血小板保持稳定,溶血检查结果显示逐渐改善。在第4天,ADAMTS13活性结果恢复正常,为61%。因此,停止血浆置换,继续肠外补充B12,这导致溶血逐渐改善,最终溶血停止,血红蛋白和血小板恢复正常。该患者壁细胞自身抗体呈阳性,因此诊断为恶性贫血。严重维生素B12缺乏的患者可能表现出类似TTP的特征,如MAHA、血小板减少和裂红细胞症。早期准确诊断假性血栓性微血管病对于给予正确的维生素B12替代治疗以及避免或缩短不必要的血浆置换治疗时间具有关键的临床意义。